Published by Michele Maatouk on 27th February 2023
(Sharecast News) - Pfizer is reportedly in talks to acquire biotech Seagen Inc, which focuses on developing and commercialising monoclonal antibody-based therapies for the treatment of cancer.
URL: http://www.digitallook.com/dl/news/story/33330068/...